Literature DB >> 35350267

The serious threat of late presenters HIV-infected patients in the context of the COVID-19 pandemic.

Pierluigi Brugnaro1, Erika Morelli1, Francesca Cattelan1, Andrea Petrucci1, Francesco Colombo1, Sara Caputo1, Licia Laurino2, Sandro Panese1.   

Abstract

The impact of current SARS-CoV-2 pandemic on the healthcare services had serious consequences, especially for the most fragile populations such as HIV-positive subjects. In the period April to September 2020 we reported four cases of HIV-infected late presenters with an AIDS-defining life-threatening condition that, due to the difficult access to the hospital during the pandemic, were characterized by a delayed HIV recognition and institution of correct treatment. Even after two decades of highly active antiretroviral therapy late presenters HIV-infected patients still represent a serious clinical challenge.
Copyright © 2022 InfezMed.

Entities:  

Keywords:  AIDS; COVID-19; late presenters; opportunistic infections

Year:  2022        PMID: 35350267      PMCID: PMC8929730          DOI: 10.53854/liim-3001-14

Source DB:  PubMed          Journal:  Infez Med        ISSN: 1124-9390


  13 in total

1.  Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma.

Authors:  Christian Grommes; James L Rubenstein; Lisa M DeAngelis; Andres J M Ferreri; Tracy T Batchelor
Journal:  Neuro Oncol       Date:  2019-02-19       Impact factor: 12.300

2.  HIV Glasgow - Virtual, 5-8 October 2020.

Authors: 
Journal:  J Int AIDS Soc       Date:  2020-10       Impact factor: 5.396

3.  Increased Risk of Anemia, Neutropenia, and Thrombocytopenia in People With Human Immunodeficiency Virus and Well-Controlled Viral Replication.

Authors:  Delal Akdag; Andreas Dehlbæk Knudsen; Rebekka Faber Thudium; Ditte Marie Kirkegaard-Klitbo; Chivit Nielsen; Peter Brown; Shoaib Afzal; Børge G Nordestgaard; Jens Lundgren; Susanne Dam Nielsen
Journal:  J Infect Dis       Date:  2019-10-22       Impact factor: 5.226

4.  Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy (HAART).

Authors:  Timo Wolf; Hans-Reinhard Brodt; Stephan Fichtlscherer; Kathleen Mantzsch; Dieter Hoelzer; Eilke B Helm; Paris S Mitrou; Kai Uwe Chow
Journal:  Leuk Lymphoma       Date:  2005-02

Review 5.  COVID-19: to be or not to be; that is the diagnostic question.

Authors:  Jamie J Coleman; Kaveh Manavi; Ella J Marson; Adam H Botkai; Elizabeth Sapey
Journal:  Postgrad Med J       Date:  2020-06-10       Impact factor: 2.401

6.  COVID-19 Pandemic Disrupts HIV Continuum of Care and Prevention: Implications for Research and Practice Concerning Community-Based Organizations and Frontline Providers.

Authors:  Rogério M Pinto; Sunggeun Park
Journal:  AIDS Behav       Date:  2020-09

7.  Trends in primary central nervous system lymphoma incidence and survival in the U.S.

Authors:  Meredith S Shiels; Ruth M Pfeiffer; Caroline Besson; Christina A Clarke; Lindsay M Morton; Leticia Nogueira; Karen Pawlish; Elizabeth L Yanik; Gita Suneja; Eric A Engels
Journal:  Br J Haematol       Date:  2016-03-28       Impact factor: 8.615

8.  Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models.

Authors:  Britta L Jewell; Edinah Mudimu; John Stover; Debra Ten Brink; Andrew N Phillips; Jennifer A Smith; Rowan Martin-Hughes; Yu Teng; Robert Glaubius; Severin Guy Mahiane; Loveleen Bansi-Matharu; Isaac Taramusi; Newton Chagoma; Michelle Morrison; Meg Doherty; Kimberly Marsh; Anna Bershteyn; Timothy B Hallett; Sherrie L Kelly
Journal:  Lancet HIV       Date:  2020-08-06       Impact factor: 12.767

9.  Impact of the COVID-19 pandemic on testing services for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region, March to August 2020.

Authors:  Daniel Simões; Annemarie Rinder Stengaard; Lauren Combs; Dorthe Raben
Journal:  Euro Surveill       Date:  2020-11
View more
  1 in total

1.  Incidence and severity prediction score of COVID-19 in people living with HIV (SCOVHIV): experience from the first and second waves of the pandemic in Indonesia.

Authors:  Evy Yunihastuti; Teguh Harjono Karjadi; Alvina Widhani; Haridana Indah Setiawati Mahdi; Salma Sundari; Aljira Fitya Hapsari; Sukamto Koesnoe; Samsuridjal Djauzi
Journal:  AIDS Res Ther       Date:  2022-10-03       Impact factor: 2.846

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.